|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/51 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 31/592 | (2006.01) | ||
| A61K 31/593 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3151853 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15802815.9 |
| Date of filing the European patent application | 2015-06-04 | |
| (97) | Date of publication of the European application | 2017-04-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation | 2020-08-10 |
| (86) | Number | PCT/SE2015/050651 |
| Date | 2015-06-04 |
| (87) | Number | WO 2015/187087 |
| Date | 2015-12-10 |
| (30) | Number | Date | Country code |
| 1450678 | 2014-06-04 | SE | |
| 1451315 | 2014-11-04 | SE |
| (72) |
ESSEN-MÖLLER, Anders, SE
LUDVIGSSON, Johnny, SE
|
| (73) |
Diamyd Medical AB,
Kungsgatan 29, 111 56 Stockholm,
SE
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Glutamo rūgšties dekarboksilazė (GAD), skirta panaudoti autoimuninės ligos gydyme |
| GLUTAMIC ACID DECARBOXYLASE (GAD) FOR USE IN THE TREATMENT OF AN AUTOIMMUNE DISEASE |
| Payment date | Validity (years) | Amount | |
| 2025-04-04 | 11 | 289.00 EUR |
| 2026-06-04 |